| Author |
Title |
Year |
Publication |
Volume  |
Pages |
| Mukerji, R.; Kakarala, R.; Smith, S.J.; Kusz, H.G. |
Chryseobacterium indologenes: an emerging infection in the USA |
2016 |
BMJ Case Reports |
2016 |
|
| Mukerji, R.; Kakarala, R.; Smith, S.J.; Kusz, H.G. |
Chryseobacterium indologenes: an emerging infection in the USA |
2016 |
BMJ Case Reports |
2016 |
|
| Medrano, L.M.; Taxonera, C.; Gonzalez-Artacho, C.; Pascual, V.; Gomez-Garcia, M.; Barreiro-de Acosta, M.; Perez-Calle, J.L.; Bermejo, F.; Lopez-Sanroman, A.; Martin Arranz, D.; Gisbert, J.P.; Mendoza, J.L.; Martin, J.; Nunez, C.; Urcelay, E. |
Response to Infliximab in Crohn's Disease: Genetic Analysis Supporting Expression Profile |
2015 |
Mediators of Inflammation |
2015 |
318207 |
| Lin, Z.; Liao, Z.; Huang, J.; Ai, M.; Pan, Y.; Wu, H.; Lu, J.; Cao, S.; Li, L.; Wei, Q.; Tang, D.; Wei, Y.; Li, T.; Wu, Y.; Xu, M.; Li, Q.; Jin, O.; Yu, B.; Gu, J. |
Predictive Factors of Clinical Response of Infliximab Therapy in Active Nonradiographic Axial Spondyloarthritis Patients |
2015 |
BioMed Research International |
2015 |
876040 |
| Guo, Y.; Zhou, G.; He, C.; Yang, W.; He, Z.; Liu, Z. |
Serum Levels of Lipopolysaccharide and 1,3-beta-D-Glucan Refer to the Severity in Patients with Crohn's Disease |
2015 |
Mediators of Inflammation |
2015 |
843089 |
